The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
Boursier, Jérôme, Mueller, Olaf, Barret, Matthieu, Machado, Mariana, Fizanne, Lionel, Araujo‐Perez, Felix, Guy, Cynthia D., Seed, Patrick C. +6 more·2016·Hepatology
Cited by (1,000)
Items 801–900 of 1,000
- Correlation between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction in non-obese adults: a cross-sectional studyFangyuan Cong, Luying Zhu, Lihua Deng, Qian Xue, Jingtong Wang · 2023 · BMC Gastroenterology
- Nutritional and Lifestyle Therapy for NAFLD in People with HIVFelice Cinque, Annalisa Cespiati, Rosa Lombardi, Giovanni Guaraldi, Giada Sebastiani · 2023 · Nutrients
- Protein kinases: The key contributors in pathogenesis and treatment of nonalcoholic fatty liver disease-derived hepatocellular carcinomaRong Liu, Mingping Qian, Ying‐Yu Cui · 2023 · Metabolism
- Honokiol affects the composition of gut microbiota and the metabolism of lipid and bile acid in methionine-choline deficiency diet-induced NASH miceTing Zhai, Junjun Wang, Yong Chen · 2023 · Scientific Reports
- Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targetsStanislav Gruzdev, Irina Viktorovna Podoprigora, Oksana Anatolievna Gizinger · 2024 · Archives of Microbiology
- Integrated analysis of metabolomic and gut microbiota reveals idiosyncratic drug-induced liver injury resulting from the combined administration of bavachin and icariside IIBo Cao, Yingying Li, Mengmeng Lin, Jing Xu, Taifeng Li, Xiaofei Fei, Xiaohe Xiao, Guohui Li, Chunyu Li · 2024 · Acupuncture and Herbal Medicine
- Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001–2023)Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan · 2024 · Frontiers in Microbiology
- Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth ComparisonMilena N. Vesković, Milka Pejović, Nikola Šutulović, Dragan Hrnčić, Aleksandra Rašić-Marković, Olivera P. Stanojlović, Dušan R. Mladenović · 2024 · International Journal of Molecular Sciences
- Liver metabolism in human MASLD: A review of recent advancements using human tissue metabolomicsEmily L. Flam, Joel T. Haas, Bart Staels · 2024 · Atherosclerosis
- Gas Chromatography-Mass Spectrometry (GC-MS) Analysis of the Volatile Oil of Cichorium Glandulosum Boiss et Huet and its Effects on Carbon Tetrachloride-Induced Liver Fibrosis in RatsDongmei Qin, Xin-Bing Wang, Nan Zou, Chang Lung Han, Jia Li Xu · 2019 · Medical Science Monitor
- Veillonella Bacteremia in Alcoholic HepatitisPatrick C. Lee, Brandon K.K. Fields, Tom Z. Liang, Michael P. Dubé, Seth Anthony Politano · 2021 · Case Reports in Hepatology
- NAD metabolic therapy in metabolic dysfunction-associated steatotic liver disease: Possible roles of gut microbiotaXinyi Lu, Rui Yang, Yu Chen, Daozhen Chen · 2024 · iScience
- Plant polyphenols delay aging: A review of their anti-aging mechanisms and bioavailabilityHao Zhang, Feijie Wang, Li Wang, Jun Du, Yan Li · 2025 · Food Research International
- Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeuticsHimani Pandey, Prabudh Goel, Varunvenkat M. Srinivasan, Daryl W. T. Tang, Sunny H Wong, Devi Lal · 2025 · World Journal of Hepatology
- Targeting gut microbiota in non-alcoholic fatty liver disease (NAFLD): Pathogenesis and therapeutic insights: A reviewShuhao Bian, Shuyao Zhu, Jiaxu Lu, Mudassar Iqbal, Tariq Jamil, Faisal Ayub Kiani, Haiju Dong, Hongyu Dai, Xiangqian Zhang, Fang Liu et al. · 2025 · International Journal of Biological Macromolecules
- Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgeryJosé Ignacio Martínez‐Montoro, Mohammad Shafi Kuchay, Andrés Balaguer Román, María Antonia Martínez‐Sánchez, María Dolores Frutos, José Carlos Fernández‐García, Bruno Ramos‐Molina · 2021 · Obesity Reviews
- Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut MicrobiotaJunbin Yan, Yunmeng Nie, Yuan Liu, Jingya Li, Liyan Wu, Zhiyun Chen, Beihui He · 2022 · Frontiers in Cellular and Infection Microbiology
- Nutrition and MicrobiomeNathalie M. Delzenne, Julie Rodriguez · 2022 · Handbook of experimental pharmacology
- Hepatoprotective Effects of Ixeris chinensis on Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice: An Integrated Gut Microbiota and Metabolomic AnalysisWenjie Jin, Sungbo Cho, Namujila Laxi, Terigele Bao, Lili Dai, Hongzhen Yu, Rigeer Qi, Junqing Zhang, Genna Ba, Minghai Fu · 2022 · Molecules
- Beneficial effects of Lactobacillus rhamnosus hsryfm 1301 fermented milk on rats with nonalcoholic fatty liver diseaseDawei Chen, Yating Liang, Jiaojiao Liang, Feifei Shen, Yue Cheng, Hengxian Qu, Yunchao Wa, Congcong Guo, Ruixia Gu, Jianya Qian et al. · 2023 · Journal of Dairy Science
- Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosisYoichi Takimoto, Po–Sung Chu, Nobuhiro Nakamoto, Yuya Hagihara, Yohei Mikami, Kentaro Miyamoto, Rei Morikawa, Toshiaki Teratani, Nobuhito Taniki, Sota Fujimori et al. · 2023 · iScience
- The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal WomenJohanna Kay DiStefano · 2023 · Nutrients
- miR-27b targets MAIP1 to mediate lipid accumulation in cultured human and mouse hepatic cellsEiko Sakai, Tsutomu Imaizumi, Ruruka Suzuki, Marcos Taracena-Gándara, Toshiki Fujimoto, Fuminori Sakurai, Hiroyuki Mizuguchi · 2023 · Communications Biology
- Beneficial effects of silibinin on serum lipids, bile acids, and gut microbiota in methionine-choline-deficient diet-induced miceWei J. Wang, Ting Zhai, Ping Luo, Xiaolei Miao, Junjun Wang, Yong Chen · 2023 · Frontiers in Nutrition
- Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitisSara Abdollahiyan, Ali Nabavi-Rad, Shahrbanoo Keshavarz Azizi Raftar, Magali Monnoye, Naghmeh Salarieh, Azam Farahanie, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Behzad Hatami, Philippe Gérard et al. · 2023 · Scientific Reports
- Liver cirrhosis and complications from the perspective of dysbiosisGuole Nie, Honglong Zhang, Danna Xie, Jun Yan, Xun� Li · 2024 · Frontiers in Medicine
- Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease PatientsQing-Yu Xiao, Ren-Ling Wang, Hai-Jun Wu, Wen-Bin Kuang, Wei-Wei Meng, Zhen Cheng · 2024 · Journal of Multidisciplinary Healthcare
- The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategiesLi Jun Wang, Jian Sun, Shu‐Cheng Chen, Youlan Sun, Yang Zheng, Jian Chao Feng · 2025 · Frontiers in Medicine
- Compromised nutritional status in patients with end-stage liver disease: Role of gut microbiotaMaria Vasco, Rossella Paolillo, Concetta Schiano, Linda Sommese, Oreste Cuomo, Claudio Napoli A · 2018 · Hepatobiliary & pancreatic diseases international
- Gut Microbiota and Liver Injury (I)—Acute Liver InjuryGuangyan Wu, Sanda Win, Tin Aung Than, Peng Chen, Neil Kaplowitz · 2020 · Advances in experimental medicine and biology
- Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulationQi Li, Wanlin Dai, Jing Kong, Yu Tian, Yongsheng Chen · 2021 · Journal of Physiology and Biochemistry
- Identification cholesterol metabolites altered before the onset of nonalcoholic steatohepatitis by targeted metabolomicsSaori Shoji, Masamitsu Maekawa, Jiro Ogura, Toshihiro Sato, Nariyasu Mano · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Retrorsine Cooperates with Gut Microbiota to Promote Hepatic Sinusoidal Obstruction Syndrome by Disrupting the Gut BarrierXiao Li, Lilin Hu, Huikuan Chu, Liuying Chen, Jingjing Yan, Weijun Wang, Xiaoqian Yang, Qingjing Zhu, Fan Du, Yuhu Song et al. · 2022 · Journal of Clinical and Translational Hepatology
- Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic SteatohepatitisTian Lan, Tonghao Xu, Yanfang Fu, Shuo Jiang, Xiaolin Liang, Ze Yu, Linyu Pan, Xianglu Rong, Jiao Guo · 2022 · Frontiers in Endocrinology
- Metabolites, gene expression, and gut microbiota profiles suggest the putative mechanisms via which dietary creatine increases the serum taurine and g-ABA contents in Megalobrama amblycephalaYizhuo Hua, Wangwang Huang, Fan Wang, Jing Zhao, Juntao Li, Qingchao Wang, Yuhua Zhao · 2023 · Fish Physiology and Biochemistry
- Gut Microbiota in Health and DiseaseEdward E. Ishiguro, Natasha Haskey, Kristina Campbell · 2018 · Elsevier eBooks
- Microbial Infections as a Trigger for Acute-on-Chronic Liver Failure: A ReviewQun Cai, Wei Liu, Mingyan Zhu, Jifang Sheng · 2019 · Medical Science Monitor
- Exploratory Research on the Relationship between Human Gut Microbiota and Portal HypertensionKeiji Yokoyama, Naoaki Tsuchiya, Ryo Yamauchi, Takashi Miyayama, Yotaro Uchida, Kumiko Shibata, Hiromi Fukuda, Kaoru Umeda, Kazuhide Takata, Takashi Tanaka et al. · 2020 · Internal Medicine
- Targeting gut microbiota and metabolism profiles with coated sodium butyrate to ameliorate high-energy and low-protein diet-induced intestinal barrier dysfunction in laying hensSasa Miao, Jiankui Li, Ying Chen, Wenyan Zhao, Mengru Xu, Fang Liu, Xiaoting Zou, Xin Dong · 2024 · Animal nutrition
- Akebia trifoliata extracts attenuate liver injury via gut–liver axis in a murine model of nonalcoholic fatty liver disease with low-grade colitisXiaoya Wang, Han Chen, Weifeng Zhu, Zhongliang Wang, Yao Pan, Yong Sun, Hua Xiong, Junmei Zhou, Wenliang Cheng, Kejun Cheng · 2025 · Food Research International
- Intestinal bacteria-derived extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From mechanisms to therapeuticsLi-Na Qin, Yunfeng Yu, Lie Ma, Rong Yu · 2025 · Molecules and Cells
- Crosstalk Between Microbiome and Ferroptosis in Diseases: From Mechanism to TherapySi‐Qi Ding, Yun Lei, Zhe‐Ming Zhao, Xin‐Yun Li, Ji‐Xuan Lang, Jia‐Kui Zhang, Yanan Li, Chun‐Dong Zhang, Dong‐Qiu Dai · 2025 · Comprehensive physiology
- Gut microbiota heterogeneity in non-alcoholic fatty liver disease: a narrative review of drivers, mechanisms, and clinical relevanceYing Guo, Naisi Zhang, Dongmei Pei · 2025 · Frontiers in Microbiology
- Microbiota reprogramming for treatment of alcohol-related liver diseaseMohamed Tausif Siddiqui, Gail Cresci · 2020 · Translational research
- Metabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implicationsCarlos J. Pirola, Silvia Sookoian · 2021 · Current Opinion in Lipidology
- Hepatoprotective Effect of Cereal Vinegar Sediment in Acute Liver Injury Mice and Its Influence on Gut MicrobiotaQijie Guan, Tingting Gong, Zhen‐Ming Lu, Yan Geng, Wenhui Duan, Yilin Ren, Xiaojuan Zhang, Li‐Juan Chai, Jin‐Song Shi, Zhenghong Xu · 2021 · Frontiers in Nutrition
- Efficacy of Biejiajian Pill on Intestinal Microbiota in Patients with Hepatitis B Cirrhosis/Liver Fibrosis: A Randomized Double-Blind Controlled TrialXin Chi, Danying Cheng, Xiu Li Sun, Shunai Liu, Rongbin Wang, Qin Chen, Huichun Xing · 2023 · Chinese Journal of Integrative Medicine
- Signs of aging in midlife: physical function and sex differences in microbiotaRoy Tzemah-Shahar, Sondra Turjeman, Efrat Sharon, Gila Gamliel, Hagit Hochner, Omry Koren, Maayan Agmon · 2023 · GeroScience
- Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)Nelson Kei, Vincent Wai‐Sun Wong, Susana Lauw, Lijun You, Peter Chi Keung Cheung · 2023 · Foods
- Composition of gut microbiota and its correlations with neurological, intestinal, cardiovascular and metabolic diseasesMorena Sciuto, Roberto Catanzaro · 2023 · Acta Microbiologica et Immunologica Hungarica
- Western diet components that increase intestinal permeability with implications on healthGilberto Jaquez-Durán, Ana Lidia Arellano-Ortiz · 2023 · International Journal for Vitamin and Nutrition Research
- Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonistAn-Na Moon, François Briand, Natália Martins Breyner, Dong Keun Song, Martin Rønn Madsen, Hongbin Kim, Keonwoo Choi, Yoonsuk Lee, Wan Namkung · 2024 · Biomedicine & Pharmacotherapy
- Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in childrenJiayou Luo, Miyang Luo, Atipatsa Chiwanda Kaminga, Jia Wei, Wen Dai, Yunlong Peng, Kunyan Zhao, Yamei Duan, Xiang Xiao, SiSi Ouyang et al. · 2024 · Microbiology Spectrum
- Dual-Stimuli-Responsive Gut Microbiota-Targeting Nitidine Chloride-CS/PT-NPs Improved Metabolic Status in NAFLDJianmei Lu, Yongzhu Zeng, Hanyu Zhong, Wei Guo, Yuyan Zhang, Wanting Mai, Yucui Qin, Xiaodan Su, Bo Zhang, Weisen Wu et al. · 2024 · International Journal of Nanomedicine
- Aging Gut Microbiome in Healthy and Unhealthy AgingWang Yangyanqiu, Zhanbo Qu, Jian Chu, Shuwen Han · 2024 · Aging and Disease
- Impact of cholecystectomy on the gut-liver axis and metabolic disordersMariana Amaral Raposo, Emília Oliveira, Andrey Santos, Dioze Guadagnini, Haquima El Mourabit, Chantal Housset, Sara Lemoinne, Mário J.A. Saad · 2024 · Clinics and Research in Hepatology and Gastroenterology
- A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASHJustine Gillard, Martin Roumain, Corinne Picalausa, Morgane M. Thibaut, Laure‐Alix Clerbaux, Anne Tailleux, Bart Staels, Giulio G. Muccioli, Laure B. Bindels, Isabelle A. Leclercq · 2024 · JHEP Reports
- Soybean oil-based HFD induces gut dysbiosis that leads to steatosis, hepatic inflammation and insulin resistance in miceTEXY K. JACOB, Sardar T. A. K. Sindhu, Amal Hasan, Md. Zubbair Malik, Hossein Arefanian, Fatema Al‐Rashed, Rasheeba Nizam, Shihab Kochumon, Reeby Thomas, Fatemah Bahman et al. · 2024 · Frontiers in Microbiology
- Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver DiseaseSamradhi Singh, Mona Kriti, Roberto Catanzaro, Francesco Marotta, Mustafa Malvi, Ajay Kumar Jain, Vinod Verma, Ravinder Nagpal, Rajnarayan Ramshankar Tiwari, Manoj Kumar · 2024 · Livers
- Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartmentsCarlos Jose Pirola, María Silvina Landa, Mariano Luis Schuman, Silvia Inés García, Adrián Salatino, Silvia C. Sookoian · 2024 · Clinical and Molecular Hepatology
- Fibrosis and the intestinal microbiome; a focus on chronic liver diseaseNaiara Beraza · 2019 · Current Opinion in Pharmacology
- Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitisMonica A. Tincopa · 2020 · Endocrinology Diabetes & Metabolism
- Burn resuscitation strategy influences the gut microbiota-liver axis in swineWayne T. Muraoka, Jose C. Granados, Belinda I. Gómez, Susannah E. Nicholson, Kevin K. Chung, Jeffrey W. Shupp, James A. Bynum, Michael A. Dubick, David Mark Burmeister · 2020 · Scientific Reports
- Changes and Correlations of the Intestinal Flora and Liver Metabolite Profiles in Mice With GallstonesYang Chen, Qiang Wang, Wenqi Gao, Biao Ma, Dongbo Xue, Chenjun Hao · 2021 · Frontiers in Physiology
- Gut microbiome and metabolic response in non-alcoholic fatty liver diseaseAsmita Madatali Abuwani, Shweta Priyadarshini Dash, Raja Ganesan, Kaviyarasi Renu, Balachandar Vellingiri, Sabariswaran Kandasamy, Sundara Rajan C.R., Abilash Valsala Gopalakrishnan · 2021 · Clinica Chimica Acta
- Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosisEmmanouil Sinakos · 2022 · Annals of Gastroenterology
- The Biotics Family: Current Knowledge and Future Perspectives in Metabolic DiseasesCodrina-Madalina Palade, Georgiana-Anca Vulpoi, Radu Alexandru Vulpoi, Vasile Liviu Drug, Oana-Bogdana Bărboi, Manuela Ciocoiu · 2022 · Life
- Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic ReviewSamuel J. Martínez‐Domínguez, Sandra G. García, Viviana Laredo, Carla J. Gargallo-Puyuelo, Beatriz Gallego Llera, Julia López de la Cruz, Fernando Gomollón · 2023 · Cancers
- Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational studyBenedetta Maria Motta, Christoph Grander, Martin Gögele, Luisa Foco, Vladimir Vuković, Roberto Melotti, Christian Fuchsberger, Alessandro De Grandi, Chiara Cantaloni, Anne Picard et al. · 2019 · Journal of Translational Medicine
- Nonalcoholic fatty liver diseaseEvangelia S. Makri, Stergios A. Pοlyzos · 2022 · Journal of Atherosclerosis Prevention and Treatment
- False ankylosis of the temporomandibular joint in a catRene T. van Ee, Robert D. Pechman · 1987 · Journal of the American Veterinary Medical Association
- Mouse model of NASH that replicates key features of the human disease and progresses to fibrosis stage 3St. Rose, Kristy, Yan, Jun, Xu, Fangxi, Williams, Jasmine, Dweck, Virginia, Saxena, Deepak, Schwabe, Robert F., Caviglia, Jorge Matias · 2022 · Hepatology Communications
- Association between bowel movement frequency, stool consistency and MAFLD and advanced fibrosis in US adults: a cross-sectional study of NHANES 2005-2010Miaomin Ye, Yijia He, Yin Yan Xia, Ziyi Zhong, Xiaocen Kong, Yunting Zhou, Weiping Wang, Suping Qin, Qian Li · 2024 · BMC Gastroenterology
- Helicobacter pylori infection and association with chronic diseases: A focus on cardiovascular disease, MASLD, and type 2 diabetesN Maleki, Alireza Mohammadzadeh, Jalal Mardaneh, Hossein Pazoki, Elyas Nattagh‐Eshtivani · 2025 · Metabolism Open
- Non-Alcoholic Fatty Liver Disease in Poultry: Risk Factors, Mechanism of Development, and Emerging StrategiesAneeqa Imtiaz, Muhammad Talha Bin Tahir, Minmeng Zhao, Daoqing Gong, Jing Ge, Tuoyu Geng · 2025 · International Journal of Molecular Sciences
- Liver MRI–derived Proton Density Fat Fraction Predicts Diabetes Risk in Patients with Obesity: A Dose-Response StudyMing Deng, Zhen Li, Li Sun, Huawei Wang, Jun Tang, Yanxin Liu, Xunuo Chen, Haibo Xu, Zhe Dai · 2025 · Radiology
- Implications of the Liver-Gut Axis in Liver Disease: From Mechanisms to Therapeutic TargetsMariana Michelle Ramírez-Mejía, Guadalupe Ponciano‐Rodríguez, Nahúm Méndez‐Sánchez · 2025 · Archives of Medical Research
- Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunitiesHuiping Zhou, Yi Huang, Chen Chen, Meiyi Song, Phillip B. Hylemon · 2026 · Pharmacological Reviews
- GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG)Ricardo Correa Barbuti, Leonardo de Lucca Schiavon, Claudia Pinto Marques Souza de Oliveira, Mário Reis Álvares‐da‐Silva, Lígia Yukie Sassaki, Maria do Carmo Friche Passos, Alberto Queiróz Farias, Luísa Leite Barros, Bruno Acatauassú Paes Barreto, Gisela Bandeira de Melo Lins de Albuquerque et al. · 2020 · Arquivos de Gastroenterologia
- Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitisLarisse Longo, Pabulo Henrique Rampelotto, Eduardo Cremonese Filippi‐Chiela, Valessa Emanoele Gabriel de Souza, Fernando Salvati, Carlos Thadeu Schmidt Cerski, Themis Reverbel da Silveira, Claudia Pinto Marques Souza de Oliveira, Carolina Uribe Cruz, Mário Reis Álvares‐da‐Silva · 2021 · World Journal of Hepatology
- Identification of a novel probiotic and its protective effects on NAFLD via modulating gut microbial communityWeitao Geng, Yang Zhang, H. J. Yang, Jing Zhang, Jingqi Zhao, Jinju Wang, Longgang Jia, Yanping Wang · 2022 · Journal of the Science of Food and Agriculture
- Impact of gut microbiota on nonalcoholic fatty liver disease: insights from a leave-one-out cross-validation studyTongtong Pan, Lihuang Su, Yiying Zhang, Fangfang Yi, Yong‐Ping Chen · 2024 · Frontiers in Microbiology
- The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver DiseaseCarlo Acierno, Riccardo Nevola, Luca Rinaldi, Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Alfredo Caturano · 2025 · Livers
- Lactobacillus plantarum 1-2-3 inhibits ferroptosis by regulating dysregulated fatty acid metabolism to protect mice from high-fat diet-induced MAFLDMeihua Zhang, Shuo Zhang, Huixian Wu, Laizhi Xu, Peichao Gao, Yixin Gao, Wentao Fan, Suquan Song · 2025 · Free Radical Biology and Medicine
- A brief review on the rising incidence of chronic kidney diseases and non-alcoholic fatty liver diseaseJudit Nagy, T Kovács · 2019 · Physiology International
- Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass SurgeryChen Fu, Yong Jian Zhou, Z. Wu, Yunze Li, Wenlong Zhou, Yong Wang · 2021 · Frontiers in Endocrinology
- Dysbiosis of gut microbiota after cholecystectomy is associated with non‐alcoholic fatty liver disease in miceQihan Wang, Qi-Fan Lu, Wen-Tao Shao, Zhao-Yan Jiang, Hai Hu · 2021 · FEBS Open Bio
- The Apparent Asymmetrical Relationship Between Small Bowel Bacterial Overgrowth, Endotoxemia, and Liver Steatosis and Fibrosis in Cirrhotic and Non-Cirrhotic Patients: A Single-Center Pilot StudyEmidio Scarpellini, Ludovico Abenavoli, Velia Cassano, Emanuele Rinninella, M. Sorge, F. Capretti, Carlo Rasetti, Gianluca Svegliati‐Baroni, Francesco Luzza, Pierangelo Santori et al. · 2022 · Frontiers in Medicine
- The Potential Effect of Chinese Herbal Formula Hongqijiangzhi Fang in Improving NAFLD: Focusing on NLRP3 Inflammasome and Gut MicrobiotaLiang Shu, Yupei Zhang, Yuanjun Deng, Yifang He, Yinji Liang, Zien Liang, Yanning Chen, Kairui Tang, Runsen Chen, Qinhe Yang · 2018 · Evidence-based Complementary and Alternative Medicine
- MicrobiomeBradley Reuter, Jasmohan Singh Bajaj · 2020 · Clinics in Liver Disease
- Cross‐linkage between bacterial taxonomy and gene functions: a study of metagenome‐assembled genomes of gut microbiota in adult non‐alcoholic fatty liver diseaseClémence M. Canivet, Norma David, Hélène Pailhories, Martial Briand, Cynthia D. Guy, Olivier Bouchez, Gilles Hunault, Lionel Fizanne, Adrien Lannes, F. Oberti et al. · 2021 · Alimentary Pharmacology & Therapeutics
- The role of bariatric surgery in the management of nonalcoholic steatohepatitisKeri A. Seymour, Manal F. Abdelmalek · 2021 · Current Opinion in Gastroenterology
- Molecular mechanisms of non-alcoholic fatty liver disease developmentTatyana S. Sall, Elena S. Shcherbakova, Stanislav I. Sitkin, Timur Vakhitov, Игорь Геннадьевич Бакулин, Elena V. Demyanova · 2021 · Russian Journal of Preventive Medicine
- Probiotics and gut healthEmidio Scarpellini, Martina BASILICO, Emanuele Rinninella, Florencia Carbone, Jolien Schol, Carlo RASETTI, Ludovico Abenavoli, Pierangelo SANTORI · 2021 · Minerva Gastroenterology
- Mouse models of nonalcoholic steatohepatitis and their application to new drug developmentHuy Hieu Phung, Chang Hoon Lee · 2022 · Archives of Pharmacal Research
- La Estoria de España de Alfonso X: creación y evoluciónDiego Catalán · 1992
- Macrophages as a source of fibrosis biomarkers for non-alcoholic fatty liver diseaseSachiyo Yoshio, Tatsuya Kanto · 2021 · Immunological Medicine
- Tartary Buckwheat Flavonoids Relieve Non-alcoholic Fatty Liver Disease by Inhibiting Lipid Accumulation, Inflammation, and Regulating Intestinal FloraPing Xu, Juxiong Liu, Zhe Li, Xingchi Kan, Guiqiu Hu, Yu Cao, Wenjin Guo, Shoupeng Fu · 2023 · Revista Brasileira de Farmacognosia
- Gentiopicroside improves high-fat diet-induced NAFLD in association with modulation of host serum metabolome and gut microbiome in miceLijuan Wang, Yuxin Jiang, Qian Yu, Chunping Xiao, Jin Sun, Lili Weng, Ye Qiu · 2023 · Frontiers in Microbiology
- Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable LinkMaria Effenberger, Christoph Grander, Felix Grabherr, Herbert Tilg · 2023 · Journal of Clinical and Translational Hepatology